A Phase I Dose Finding Study in Children With Solid Tumors Recurrent or Refractory to Standard Therapy

Clinical trial NCT02085148 · COMPLETED

Trial details

NCT number: NCT02085148
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric Oncology

Start date: 2014-04-11
Primary completion: 2019-05-05
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.